Acura Pharmaceuticals, Inc. Stock Nasdaq
Equities
US00509L8028
Biotechnology & Medical Research
Sales 2020 | 3.57M 4.87M | Sales 2021 | 1.56M 2.13M | Capitalization | 32.54M 44.4M |
---|---|---|---|---|---|
Net income 2020 | -1M -1.36M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 7.99M | Net Debt 2021 | 135K 184K | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.72% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 08-04-06 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 98-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bruce Wesson
BRD | Director/Board Member | 81 | 98-02-28 |
William Skelly
BRD | Director/Board Member | 73 | 96-04-30 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |